The FDA approved the first nalmefene hydrochloride auto-injector (Zurnai) for use as an emergency treatment for opioid overdose in adults and children 12 years of age and older, the agency announced ...
WALTHAM, Mass., June 26, 2017 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) today announced that the U.S. Food and Drug Administration (FDA) accepted the supplemental new drug ...
Emergent BioSolutions ($EBS) has launched a military-grade intramuscular auto-injector device for self-administered antidotes or other chemical threat treatments. For ...
YORK, Pa., Aug. 30, 2011 /PRNewswire/ -- Unilife Corporation ("Unilife" or the "Company") (NASDAQ: UNIS; ASX: UNS) today announced the development of a unique proprietary range of auto-injectors for ...
The European Medicines Agency (EMA) has recommended several measures to better ensure appropriate patient and carer use of adrenaline auto-injectors for severe allergic reactions. The move is prompted ...
Anaphylaxis is a serious, potentially life-threatening allergic reaction that can affect several organ systems in the body and may threaten breathing and blood circulation. The most common causes of ...
An adrenaline auto-injector is an emergency treatment for anaphylaxis; serious and potentially fatal allergic reaction to insect stings, medicines, or food, among others. Anaphylaxis is an ...
Anaphylaxis is a serious, potentially fatal allergic reaction. It can happen within seconds to minutes of exposure to an allergen, like an insect sting, medications, and food. When the immune system ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results